Peroxisome Proliferator-Activated Receptor-γ Activator 15-Deoxy-Δ12,14-Prostaglandin J2 Inhibits Neuroblastoma Cell Growth through Induction of Apoptosis: Association with Extracellular Signal-Regulated Kinase Signal Pathway

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 2, 2003, Pages 505-517

  Kim, Eun Joung ^a   Park, Ki Sook ^a   Chung, Soo Youn ^a   Sheen, Yhun Yhong ^b   Moon, Dong Chuol ^c   Song, Yeun Sook ^c   Kim, Kyong Soon ^c   Song, Sukgil ^c   Yun, Yeo Pyo ^c   Lee, Myung Koo ^c   Oh, Ki Wan ^c   Yoon, Do Young ^d   Hong, Jin Tae ^c  

^a Korea Food and Drug Administration   (South Korea)

^b Ewha Womans University   (South Korea)

^c Chungbuk National University   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 CHLORO 5 NITROBENZANILIDE; CASPASE 3; CASPASE 9; CELL CYCLE PROTEIN; CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; DNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ANTAGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CELL VIABILITY; DNA CONTENT; ENZYME ACTIVATION; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANILIDES; APOPTOSIS; BIOLOGICAL RESPONSE MODIFIERS; CASPASE 3; CASPASES; CELL DIVISION; CYCLIN B; DRUG INTERACTIONS; G2 PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; MITOGEN-ACTIVATED PROTEIN KINASES; MITOSIS; NEUROBLASTOMA; NF-KAPPA B; ORGANIC CHEMICALS; PROSTAGLANDIN D2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0142210246     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.053876     Document Type: Article

References (35)

1. Andoh T, Chock PB, and Chiueh CC (2002) The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. J Biol Chem 277:9655-9660.
2. Bentires-Alj M, Dejardin E, Viatour P, Lint CV, Froesch B, Reed JC, Merville MP, and Bours V (2001) Inhibition of the NF-κB transcription factor increases Bax expression in cancer cell lines. Oncogene 20:2805-2813.
3. Berger J and Moller DE (2002) The mechanisms of action of PPARs. Annu Rev Med 53:409-435.
4. Blazquez C, Galve-Roperh I, and Guzman M (2000) De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase. FASEB J 14:2315-2322.
5. Boelsterli UA and Bedoucha M (2002) Toxicological consequences of altered peroxisome proliferator-activated receptor gamma (PPARgamma) expression in the liver: insights from models of obesity and type 2 diabetes. Biochem Pharmacol 63:1-10.
6. Dai Y, Yu C, Singh V, Tang L, Wang Z, McInistry R, Dent P, and Grant S (2001) Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells. Cancer Res 61:5106-5115.
7. Eibl G, Wente MN, Reber HA, and Hinesm OJ (2001) Peroxisome proliferator-activated receptor γ induces pancreatic cancer cell apoptosis. Biochem Biophys Res Commun 287:522-529.
8. Fletcher L, Cheng Y, and Muschel RJ (2002) Abolishment of the Tyr-15 inhibitory phosphorylation site on cdc2 reduces the radiation-induced G(2) delay, revealing a potential checkpoint in early mitosis. Cancer Res 62:241-250.
9. Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E, and Sanchez I (1997) Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci USA 94:3302-3307.
10. Gregory JM and Julie CH (2000) PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol Sci 21:469-474.
11. Han S, Wada RK, and Sidell N (2001b) Differentiation of human neuroblastoma by phenylacetate is mediated by peroxisome proliferator-activated receptor gamma. Cancer Res 61:3998-4002.
12. Han SW, Greene ME, Pitts J, Wada RK, and Novel NS (2001a) Expression and function of peroxisome proliferator-activated receptor gamma (PPARγ) in human neuroblastoma cells. Clin Cancer Res 7:98-104.
13. Haydon RC, Zhou L, Feng T, Breyer B, Cheng H, Jiang W, Ishikawa A, Heabody T, Montag A, Simon MA, et al. (2002) Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res 8:1288-1294.
14. Hwang BY, Lee JH, Nam JB, Kim HS, Hong YS, and Lee JJ (2002) Two new furanoditerpenes from Saururus chinenesis and their effects on the activation of peroxisome proliferator-activated receptor gamma. J Nat Prod 65:616-617.
15. Jung KM, Park KS, Oh JH, Jung SY, Yang KH, Song YS, Son DJ, Park YH, Yun YP, Lee MK, et al. (2003) Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2. Mol Pharmacol 63:607-616.
16. Keelan JA, Sato TA, Marvin KW, Lander J, Gilmour RS, and Mitchell MD (1999) 15-Deoxy-delta(12,14)-prostaglandin J(2), a ligand for peroxisome proliferator-activated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells. Biochem Biophys Res Commun 262:579-585.
17. Kim SS, Chae HS, Bach JH, Lee MW, Kim KY, Lee WB, Jung YM, Bonventre JV, and Suh YH (2002) P53 mediates ceramide-induced apoptosis in SKN-SH cells. Oncogene 21:2020-2028.
18. Kitamura S, Miyazaki Y, Shinomura Y, Kondo S, Kanayama S, and Matsuzawa Y (1999) Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells. Jpn J Cancer Res 90:75-80.
19. Koniaras K, Cuddihy AR, Christopoulos H, Hogg A, and O'Connell MJ (2001) Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene 20:7453-7463.
20. Kubota T, Koshizuka K, Williamson EA, Asou H, Said JW, Holden S, Miyoshi I, and Koeffler HP (1998) Ligand for peroxisome proliferator-activated receptor γ (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res 58:3344-3352.
21. Lee JH, Kim HS, Jeong SY, and Kim IK (1995) Induction of p53 and apoptosis by Δ12-PGJ2 in human hepatocarcinoma SK-HEP-1 cells. FEBS Lett 368:348-352.
22. Mackeigan JP, Collins TS, and Ting YPJ (2000) MEK inhibition enhances paclitaxel-induced tumor apoptosis. J Biol Chem 275:38953-38956.
23. Mauricio JR, Samuel LK, Shannon TB, and Mitchell AL (1998) Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor γ. J Biol Chem 273:1855-1858.
24. Mohr S, McCormick TS, and Lapetina EG (1998) Macrophages resistant to endogenously generated nitric oxide-mediated apoptosis are hypersensitive to exogenously added nitric oxide donors: dichotomous apoptotic response independent of caspase 3 and reversal by the mitogen-activated protein kinase kinase (MEK) inhibitor PD 098059. Proc Natl Acad Sci USA 95:5045-5050.
25. Mueller E, Sarraf P, Tontonoz P, Evans RM, Martin KJ, Zhang M, Fletcher C, Singer S, and Spiogelman BM (1998) Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell 3:465-701.
26. Oh-hashi K, Maruyama W, Yi H, Takahashi T, Naoi M, and Isobe K (1999) Mitogen-activated protein kinase pathway mediates peroxynitrite-induced apoptosis in human dopaminergic neuroblastoma SH-SY5Y cells. Biochem Biophys Res Commun 263:504-509.
27. Racke MM, Mosior M, Kovacevic S, Chang CH, Glasebrook AL, Roehm NW, and Na S (2002) Activation of caspase-3 alone is insufficient for apoptotic morphological changes in human neuroblastoma cells. J Neurochem 80:1039-1048.
28. Schwartz PS and Waxman DJ (2001) Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells. Mol Pharmacol 60:1268-1279.
29. Seo SR, Chong SA, Lee SI, Sung JY, Ahn YS, Chung KC, and Seo JT (2001) Zn2+-induced ERK activation mediated by reactive oxygen species causes cell death in differentiated PC12 cells. J Neurochem 78:600-610.
30. Shankar SL, Mani S, O'Guin KN, Kandimalla ER, Agrawal S, and Shafit-Zagardo B (2001) Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways. J Neurochem 79:426-436.
31. Tsubouchi Y, Sano H, Kawahito Y, Mukai S, Yamada R, Kohno M, Ichiro K, Hla T, and Kondo M (2000) Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-γ agonists through induction of apoptosis. Biochem Biophys Res Commun 270:400-405.
32. Vincent I, Jicha G, Rosado M, and Dickson DW (1997) Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 17:3588-3598.
33. Xin X, Yang S, Kowalski J, and Gerritsen ME (1999) Peroxisome proliferator-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo. Biol Chem 274:9116-9121.
34. Yamakawa-Karakida N, Sugita K, Inukai T, Goi K, Nakamura M, Uno K, Sato H, Kagami K, Barker N, and Nakazawa S (2002) Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity. Cell Death Differ 9:513-526.
35. Yu W, Liao QY, Hantah FM, Sanders BG, and Kline K (2001) Activation of extracellular signal-regulated kinase and e-Jun-NH2-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-α-tocopheryl succinate-induced apoptosis of human breast cancer cells. Cancer Res 61:6569-6576.